-
China's new crown vaccine may be able to effectively resist the SARS-CoV-2 mutant strain
Time of Update: 2021-01-19
Chinese pharmaceutical giant China Pharmaceutical Holdings last week obtained "conditional" approval for its vaccine candidate, and manufacturers said they were confident the vaccine would be effective despite the rapid spread of a new mutation, the SARS-CoV-2 virus.
-
2020 inventory: China's 2 categories of "improved new drugs" analysis, Jiangsu Hengrui, Nanjing Shenghe...
Time of Update: 2021-01-19
developed by Jiangsu Hengrui made 2.1 and 2.2 registration declarations, respectively. NDA varieties, only Nanjing Sheng and Pharmaceutical Co., Ltd.'s zuo nitrosium tablets, approved for production. Table 1.1 2020 Domestic Chemical Drugs 2.1
-
Gilead's new shell functional inhibitor lenspavir Phase 2/3 clinical end point!
Time of Update: 2021-01-19
failed treatments (functional monotherapy). of the 24 people randomly assigned to the lensapavir group, the median baseline virus load was 4.2 log10 copies/mL, and 67% of the subjects had a CD4 count below 200/uL. At the end of the 14-day
-
Unrasing the Code of Aging 2 studies in the same period in the journal Nature put forward new ideas for anti-aging therapy
Time of Update: 2021-01-19
The niacinamide adenine dinucleotide, referred to simply as NAD, is a key metabolite of cell energy metabolism and a star in the field of anti-aging in recent years. studies have shown that, as we age, the level of NAD-plus in animals decays
-
Notice of the General Administration of Market Supervision on the Non-conformity of 7 Batches of Food (No. 2 of 2020)
Time of Update: 2021-01-19
exceeded the standard, heavy metal pollution, food additives over-range use, quality indicators are not up to standard and other issues. For non-conforming food found in the sampling, the General Administration of Market Supervision has tasked
-
Engli Net Milestone Phase 3 Clinical: Treatment of Type 2 Diabetes significantly reduces the risk of cardiovascular events
Time of Update: 2021-01-19
in adult patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD), jardiance or placebo combined standard care was treated. , Jardiance reduced the overall risk of cardiovascular events (first plus recurrence) compared
-
Shanghai sampling 612 batches of food, zinc gluconate oral solution, such as 2 batches of non-conformity
Time of Update: 2021-01-19
Pharmaceutical Co., Ltd. production, Shanghai Baodao Yuanshentang Big Pharmacy Co., Ltd. sales of Xin brand zinc gluconate oral solution (unqualified item: lead). Regarding the non-conforming products found in the above-mentioned sampling, the Bureau
-
2 more than 2 billion injections Koren, Howson's first review
Time of Update: 2021-01-19
.)/glucose (48%) electrolyte injections, pyrethroid injections were evaluated exclusively. Tidecycline is a new broad-spectrum antibiotic developed by Pfizer, which is also active against methicillin-resistant Staphylococcus aureus
-
Nat Microbiol: Study reveals characteristics of SARS-CoV-2 infection with primates
Time of Update: 2021-01-19
study is also the first to report that SARS-CoV-2 infection specifically alters lung lymphocytes (T-cells), producing a strong and very specific immune response in macaques that allows animals to remove the virus.
-
Chinese mainland of the Type 2 Diabetes Randomized Controlled Clinical Trial (RCT) study -- Lancet Diabetes Endocrinol
Time of Update: 2021-01-18
levelled off after 2010, with 60 additional clinical trials of type 2 diabetes started each year.
-
Diabetic combined kidney disease or heart failure patients benefited more from SGLT1/2 inhibitors
Time of Update: 2021-01-18
Screenshot Source: The New England Journal of MedicineSOLOIST trial assesses the risk of death from cardiovascular causes and re-hospitalization and emergency care due to type 2 diabetes and recent heart failure.
-
Lancet sub-journal: Testosterone or can treat type 2 diabetes in men?!
Time of Update: 2021-01-18
Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.
-
Science paper details! New research suggests that protective immunity to SARS-CoV-2 lasts eight months or more
Time of Update: 2021-01-18
pathogens to the new coronavirus SARS-CoV-2 can last at least eight months after the initial symptoms of infection appear. results were published online January 6, 2021 in the journal Science under the title "Immunological memory to SARS-CoV-2
-
The Lancet sub-| Ningguang Academician Team: Systematic evaluation of type 2 diabetes randomized controlled trial in China
Time of Update: 2021-01-18
evidence of high-quality randomized controlled clinical trials (RCTs) in patients from China, so clinical practice guidelines for DM management in Chinese adults are very similar to 1000 in Europe and North America. the growing burden of DM, China
-
New anti-inflammatory drugs! AbbVie IL-23 inhibitor Skyrizi treats psoriasis arthritis 2 Phase III studies have been successful!
Time of Update: 2021-01-18
January 07, 2021 // -- AbbVie recently announced positive topline results for two Phase 3 studies (KEEPsAKE-1 and KEEPsAKE-2) evaluating the treatment of active psoriasis arthritis (PsA) adult patients with the new anti-inflammatory drug IL-23 inhibitor Skyrizi (risankizumab).
-
4 Drug companies were punished with 2 causes of complaints reported
Time of Update: 2021-01-17
information: among them, Sichuan Zhuoyu Pharmaceutical Co., Ltd. production and sales batch number 170601 clams, Sichuan Tongshantang Chinese medicine tablets limited liability company production and sales party ginseng, there are complaints about
-
2 billion injections, the first review! The market for 60 billion cephalospora injections has been evaluated by eight products
Time of Update: 2021-01-16
On January 5, NMPA's official website published the latest drug approval information, Chengdu Ptot Pharmaceuticals injection cephalosporine sodium 4 specifications all passed the consistent evaluation.
-
ESMO Open: Incidence of pathogenic BRCA1/2 embryoline mutations in pancreatic cancer patients
Time of Update: 2021-01-16
pancreatic cancer patients of any age, gBRCApv screening at the Italian Oncology Centre within 3 months of diagnosis, with no choice.
-
Notice of hebei Provincial Market Supervision Administration on the non-conformity of 2 batches of food products (No. 15 of 2019)
Time of Update: 2021-01-16
value of 1:29CFU/mL; sample 2:<1CFU/mL; sample 3 :< 1CFU/mL; Sample 4:<1CFU/mL; Sample 5:<1CFU/mL, standard values n=5, c=0, m=0CFU/mL. inspection agency is Zhangjiakou City Food and Drug Inspection Center. , the above-mentioned sampling
-
The performance characteristics of fin tube thermal anti-corrosion coatings
Time of Update: 2021-01-16
Fin tube is to improve heat exchange efficiency, usually through fins on the surface of the heat exchange tube, increase the surface area (or internal surface area) of the heat exchange tube, so as to achieve the purpose of improving heat
